Kopran Investor Presentation: Key Takeaways
Kopran Q2 FY27 consolidated revenue ₹21,126 Lakh (+79% YoY), EBITDA ₹1,822 Lakh (8.62%), PAT ₹439 Lakh vs prior-year loss; borrowings up.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
25 announcements with these filters
Kopran Q2 FY27 consolidated revenue ₹21,126 Lakh (+79% YoY), EBITDA ₹1,822 Lakh (8.62%), PAT ₹439 Lakh vs prior-year loss; borrowings up.
Kopran Ltd reported revenue from operations of ₹211.3 Cr (+79.2% YoY) and net profit of ₹4.4 Cr for Q2 FY27.
Kopran Ltd intimates a board meeting on November 3, 2026, to consider and approve Q2 FY27 unaudited financial results. No financial figures are disclosed in this advance notice.
Kopran's Khopoli formulation facility concluded an EU GMP inspection with no critical or data-integrity observations. The company will submit compliance responses for one major and minor findings within two weeks.
Kopran Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Sarvamangal Mercantile Company Limited acquired 170,000 shares of Kopran Ltd through market purchases. The transaction increases the promoter group's stake in the target company by 0.35%.
Kopran Limited responded to NSE's price-movement query stating no material information was withheld. The stock's rise is attributed to purely market-driven forces.
Kopran Limited allotted 40,500 equity shares to employees under its ESOP 2023 scheme. The exercise price for these shares is Rs 179 per share.
United Shippers, a promoter of Kopran, sold 12,00,000 shares in the open market on 07 Sept 2026. Its stake fell from 4.56% to 2.07%.
Kopran Limited clarified to NSE that the recent increase in trading volume is purely market-driven. The company confirmed it has not withheld any material price-sensitive information.
Kopran Ltd held its 67th Annual General Meeting on August 18, 2026, where all items were passed. Voting results and the Scrutinizer's Report were submitted.
Kopran Ltd reported Q1 FY27 revenue of ₹15,399 Lakhs with a 10.31% EBITDA margin, focusing on API and Formulation verticals across 50+ nations.
Kopran Ltd reported revenue from operations of ₹154 Cr (+13.9% YoY) and net profit of ₹6.7 Cr (-9.5% YoY) for Q1 FY27.
Kopran Ltd has submitted its Annual Report for FY 2025-26, including the notice of its 67th Annual General Meeting scheduled for August 18, 2026.
Kopran Ltd has scheduled a board meeting for August 07, 2026, to consider and approve its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Kopran Limited fixed August 11, 2026, as the record date for dividend payments. The dividend is subject to approval at the AGM scheduled for August 18, 2026.
Kopran Limited appointed Mr. Vijay L Thange as Chief Technical Officer. He brings over 36 years of experience in the pharma sector.
Kopran Limited shareholders and creditors approved the Scheme of Amalgamation with Kopran Laboratories Limited. The resolution passed with requisite majority during the NCLT-convened meetings.
Kopran Ltd submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory adherence with no significant non-compliances.
Kopran Limited recommended a final dividend of ₹3 per equity share for FY 2025-26. Shareholders will vote for approval at the upcoming August 18 general meeting.
Kopran Ltd reported highest-ever quarterly revenue of ₹23,402 lakhs and EBITDA of ₹4,057 lakhs in Q4-FY26, driven by strong growth in APIs and Formulations.
Kopran Limited appointed Mrs. Namrata Varun Somani as a Non-Executive Director for five years. This strategic board addition strengthens leadership and brings legal expertise.
Kopran Ltd reported revenue from operations of ₹234 Cr (+35.7% YoY) and net profit of ₹18.9 Cr (+94.8% YoY) for Q4 FY26.
Kopran Limited reported audited FY2026 financial results and recommended a ₹3.00 per share dividend. The board also appointed Namrata Somani as a non-executive promoter group director.
Kopran's subsidiary KRLL will raise ₹18.75 Crore through a 1:12 rights issue. Proceeds will fund working capital requirements, strengthening the subsidiary's operational liquidity.